Glaucoma eye drops work by lowering the pressure inside your eye, either by reducing the amount of fluid your eye produces or by helping that fluid drain more efficiently. Some drops do both. Your eye constantly produces a clear fluid called aqueous humor that nourishes its internal structures, and this fluid normally drains out through tiny channels. When drainage slows or fluid production is too high, pressure builds and can damage the optic nerve. Different classes of drops target different parts of this system, and understanding which one you’re using helps explain both why it works and what side effects to expect.
How Eye Pressure Builds Up
Your eye is not a hollow ball. It’s filled with fluid that’s continuously refreshed. The ciliary body, a ring of tissue behind your iris, produces aqueous humor at a steady rate. That fluid flows forward through the pupil, bathes the front of the eye, and drains out primarily through a spongy tissue called the trabecular meshwork, located where the iris meets the cornea. A secondary drainage route runs through the muscle fibers behind the iris, called the uveoscleral pathway.
Glaucoma drops intervene at one or more of these points: slowing the faucet, opening the drain, or both. Your doctor chooses a class based on how much pressure reduction you need, how your body tolerates the medication, and whether you’re already on other drops.
Prostaglandin Analogs: Opening the Drain
Prostaglandin analogs are the most commonly prescribed first-line glaucoma drops, and they’re the most effective single-drug option available. They work primarily by widening the uveoscleral drainage pathway, the secondary route that runs through the ciliary muscle and out through the white of the eye. These drops trigger enzymes that remodel the connective tissue between muscle bundles, essentially loosening the fibers so fluid passes through more easily. They also relax the ciliary muscle itself, further reducing resistance to outflow. Some research shows they improve drainage through the trabecular meshwork as well.
The result is a meaningful drop in eye pressure with once-daily dosing, typically applied at bedtime. Common side effects are mostly cosmetic and local: reddening of the eye, darkening of the iris over time, longer and thicker eyelashes, and slight changes in the appearance of the upper eyelid. These drops have no significant systemic side effects, which is a major advantage over several other classes.
Beta-Blockers: Turning Down the Faucet
Beta-blocker drops take the opposite approach. Instead of improving drainage, they reduce the amount of fluid your eye makes in the first place. They block nerve receptors on the ciliary body, the tissue responsible for producing aqueous humor. With less fluid entering the eye, pressure drops.
These drops are effective and well-established, but they come with a broader side effect profile than prostaglandins. Because some of the medication can enter your bloodstream through the tear ducts and nasal membranes, beta-blockers can slow your heart rate, lower blood pressure, and worsen asthma or other breathing conditions. They can also cause fatigue, depression, and dizziness in some people. This is one reason proper drop technique matters so much (more on that below).
Alpha Agonists: A Dual Approach
Alpha agonist drops, the most common being brimonidine, work on both sides of the pressure equation. They reduce aqueous humor production and stimulate drainage through the uveoscleral pathway. This dual mechanism makes them useful as add-on therapy when a single drug isn’t enough.
The most common side effects with long-term use include eye redness, allergic reactions in the eye, drowsiness, dry mouth, and mild drops in blood pressure. Allergic conjunctivitis is particularly common with brimonidine and sometimes requires switching to a different class.
Carbonic Anhydrase Inhibitors: Blocking Fluid Production
These drops work by inhibiting a specific enzyme in the ciliary body that’s essential for producing aqueous humor. That enzyme helps generate bicarbonate ions, which drive fluid secretion. Block the enzyme, and fluid production slows. Their pressure-lowering effect is more modest than prostaglandins, so they’re most often used as a supplementary treatment alongside other drops rather than on their own. They can cause stinging or burning on application and sometimes leave a bitter taste in the mouth.
Rho Kinase Inhibitors: Targeting the Main Drain
This newer class takes a different angle. Rho kinase inhibitors directly target the trabecular meshwork, the primary drainage channel responsible for most of your eye’s fluid outflow. They relax the cells in this tissue, reducing resistance so fluid flows out more freely. They also lower the pressure in the tiny veins that carry fluid away from the eye, which further reduces overall eye pressure.
Their pressure-lowering effect as a standalone treatment is more modest compared to prostaglandins, so they’re often prescribed in combination. The most common side effect is redness of the eye, which can be noticeable but is generally harmless.
Combination Drops and Why They Exist
Many people with glaucoma need more than one type of drop to reach their target pressure. Rather than juggling two separate bottles with different schedules, combination drops merge two medications into one. This reduces the number of times you need to apply drops each day, cuts your exposure to preservatives, and makes it easier to stick with treatment long-term.
Available combinations in the U.S. include drops that pair a carbonic anhydrase inhibitor with a beta-blocker, and drops that pair an alpha agonist with a beta-blocker. Both combinations lower pressure more effectively than either ingredient used alone. In studies, the alpha agonist/beta-blocker combination was at least as effective as the other pairing and caused significantly less stinging and burning on application.
Why Preservative-Free Drops Matter
Most traditional eye drops contain a preservative called benzalkonium chloride that keeps the bottle sterile after opening. The problem is that glaucoma is a lifelong condition, and years of daily preservative exposure can irritate the surface of your eye, causing dryness, redness, and discomfort. This ocular surface damage often makes people less likely to use their drops consistently, which defeats the purpose.
Preservative-free versions now exist for several drug classes, including prostaglandin analogs, beta-blockers, carbonic anhydrase inhibitors, and some combinations. These formulations lower pressure just as effectively as their preserved counterparts while causing significantly less surface irritation. They’re especially worth discussing with your doctor if you use multiple drops daily, have dry eye symptoms, or may need glaucoma surgery in the future, since chronic inflammation from preservatives can complicate surgical outcomes.
How to Apply Drops Correctly
Technique matters more than most people realize. A drop that rolls off your cheek or drains straight into your nose isn’t treating your glaucoma, and medication absorbed through nasal membranes enters your bloodstream, increasing the risk of side effects like slowed heart rate or low blood pressure.
Lie down flat with your face up for the best chance of getting the drop where it needs to go. Gently pull your lower eyelid down, hold the bottle about an inch above your eye with the tip pointing straight down, and squeeze out a single drop. One drop is enough, even if the bottle label suggests two. Don’t let the bottle tip touch your eye.
Once the drop lands, don’t blink or move your eye around. Instead, gently close both eyes and press the pad of one finger against the inner corner of your eyelid, right next to your nose. This blocks the tear duct that would otherwise carry the medication into your nasal passages. Hold this position for two full minutes. Studies show it takes that long for the drop to fully penetrate the eye’s surface. After two minutes, the medication is absorbed and you can open your eyes. If you use more than one type of drop, wait at least five minutes between them so the first drop isn’t washed away by the second.
What Pressure Reduction Actually Looks Like
The goal of treatment isn’t to eliminate eye pressure entirely. It’s to lower it enough to stop or slow nerve damage. A 20% reduction in pressure has been shown to significantly reduce the risk of developing glaucoma in people with high eye pressure and to delay progression in those already diagnosed. Prostaglandin analogs typically achieve reductions of 6 to 8 mmHg from baseline, with greater reductions in eyes that start with higher pressures. Other classes generally produce more modest reductions, which is why they’re frequently combined.
Your target pressure depends on how advanced your glaucoma is, how high your pressure started, and whether you’re showing signs of progression. Drops are checked at follow-up visits where your doctor measures your pressure and examines the optic nerve to make sure the current regimen is doing its job. If one class isn’t enough or causes intolerable side effects, switching or adding a second drop is standard practice.